Richter syndrome of chronic lymphocytic leukemia research hub

A Multi-Center, Open Label, Uncontrolled, Phase II Clinical Trial Evaluating the Safety and Efficacy of Venetoclax in Combination with Atezolizumab and Obinutuzumab in Richter Transformation of CLL

This study is testing a new combination of medicines (Venclexta, Tecentriq, and Gazyvaro) for adults with Richter Transformation, a type of aggressive cancer linked to chronic lymphocytic leukemia (CLL). Doctors want to see if this treatment is safe and helps shrink the cancer.